NSAID API Market Analysis 2012 to 2017 - Industry Trends and Forecast 2017-2025
Active pharmaceutical ingredients (APIs) are bulk drug products that are used as raw materials for formulations. Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that groups together drugs that provide analgesic (pain-killing) and antipyretic (fever-reducing) effects, and, in higher doses, anti-inflammatory effects. The term nonsteroidal distinguishes these drugs from steroids, which, among a broad range of other effects, have a similar eicosanoid-depressing, anti-inflammatory action. APIs of good quality is essential for the manufacture of effective and safe medicines. The growing pool of geriatrics is driving the demand for various types of drugs, which in turn is leading to a soaring demand of NSAID API market. However, not all pharmaceutical companies possess in-house API manufacturing capabilities. Furthermore, a single company cannot produce all the APIs required for their formulation offerings.
NSAID API Market: Drivers and Restraints
The improving access to healthcare with the rapid penetration of technology and other developments in the healthcare sector has increased the consumption of drugs, thereby directly creating a positive impact on NSAID API market. Furthermore, growing healthcare budgets of developed and developing countries are also making a significant contribution towards propelling the sale of NSAID API market. Furthermore, the compliance by Indian active pharmaceutical ingredients manufacturers with U.S. FDA norms is also anticipated to result in increasing applications of this substance.
Get Sample Copy of this report @ https://www.marketresearchreports.biz/sample/sample/12819
NSAID API Market: Segmentation
The market for NSAID API is segmented by product type, by a manufacturing process, by drug type and regions:
By product type, the NSAID API market can be segmented into,
By manufacturing process, the NSAID API market can be segmented into,
Contract M anufacturing
By drug type, the NSAID API market can be segmented into,
Branded Prescription Drugs
Generic Prescription Drugs
The captive API manufacturing segment is witnessing a continuous decline in the global NSAID API market due to the high degree of competition and reduced profitability. High research & development costs and pricing pressure on finished products are important factors due to which pharmaceutical companies prefer outsourcing their API production instead of in-house manufacturing.
Request For TOC Report @ https://www.marketresearchreports.biz/sample/toc/12819
NSAID API Market: Overview
The global pharmaceutical industry has suffered enormously due to patent expiry of blockbuster drugs in the past few years. However, this has facilitated a surge in demand for low-cost substitutes across the globe resulting in a boost to NSAID API manufacturing. The approvals of biosimilars in Europe has added to the total NSAID API market revenue. Advancements in the production technology have enabled the production of biosimilars that are not exact copies of innovator drugs, but highly comparable regarding safety and efficacy. Europe has been the frontrunner in approving biosimilars, and the WHO has also set guidelines on similar lines of those set by the European Union. Regulatory pathways in the biosimilars space in different nations are evolving, and this implies a great market opportunity ahead for the biopharmaceutical companies.
NSAID API Market: Region-wise Outlook
Regionally, the market can be segmented into North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa. North America dominated the global NSAID API market due to high demand for APIs in drug formulations and research and development programs in this region. The region is expected to continue its dominance in the coming years owing to increasing preference for generic medicines as a result of high healthcare costs in the U.S. Among other regions, Asia-Pacific is the next largest market for APIs. This region has become the most attractive market due to clustering of a large number of generic medicine manufacturers.
NSAID API Market: Key Players
Some of the players of NSAID API market include Aurobindo Pharma, Boehringer Ingelheim Group, Cambrex Corporation, Dr. Reddy’s Laboratories, Ltd., BASF SE, Hospira, Inc., Lonza Group, Mylan, Inc., Novartis AG, Pfizer, Inc., Sandoz (Novartis AG), Teva Pharmaceutical Industries Ltd., Actavis Plc, Wuxi Apptec, and Zhejiang NHU Co., Ltd. Currently, these players are focusing on partnering with other companies to acquire a new line of products to add value to their portfolio. Furthermore, companies are also anticipated to focus on expanding their capacities to cater to the vast unmet medical needs of the world.
Request To PRE BOOK This Premium Report From Here @ https://www.marketresearchreports.biz/checkout?rep_id=12819&licType=S
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
90 Sate Street, Suite 700
Albany, NY 12207
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release NSAID API Market Analysis 2012 to 2017 - Industry Trends and Forecast 2017-2025 here
News-ID: 1458294 • Views: 290
More Releases for APIs
Global HP (High Potency) APIs Market | Global HP (High Potency) APIs Industry | …
The high potency APIs (HPAPI) market involves of sales of high potency energetic pharmaceutical ingredients and interrelated services. High potency APIs are tremendously effective in pharmacologically vigorous ingredients. These are exceedingly specific in their action and offer momentous efficiency even at the lower daily therapeutic doses. HPAPIs are utilized in formulations for great potent drugs, due to their ability to target precise syndrome cells involving the cancer cells. According to the
Global Platinum-based Anticancer APIs Market Analysis (2020-2025)
Global Info Research offers a latest published report on Platinum-based Anticancer APIs Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Platinum-based Anticancer APIs Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure
Highly Potent APIs 2019 Conference: Interview with Bayer Pharma
Dr Ulrich Rüemenapp, Head of Launch Preparation and Coordination at Bayer Pharma, will be discussing late stage CMC development and bio-manufacturing for fast track projects at SMi’s 3rd annual Highly Potent Active Pharmaceutical Ingredients conference. Ahead of the conference next month, SMi interviewed him where he gave his thoughts on how the industry has progressed and what the future holds for the industry. Ulrich said: “From my point of view the hype
Aspose Launches New Java APIs for Creating & Manipulating XPS Documents
What's New in this Release? Aspose is proud to expand its Java APIs family with the addition of a new product known as Aspose.XPS for Java. This Java API has been built to allow developers to create, edit and save new as well as existing XPS documents. You can utilize the API in Desktop GUI Applications, Web Applications and Console Applications etc. Various features regarding creating objects in XPS documents, editing
Global Konjac Glucomannan Market 2018- APIS, AuNutra, Shaanxi Top Pharm
Apex Market Reports, recently published a detailed market research study focused on the "Global Konjac Glucomannan Market" across the global, regional and country level. The report provides 360° analysis of "Global Konjac Glucomannan Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the Global Konjac Glucomannan industry, and estimates the future trend of Global
A2P SMS Market Innovative Messaging Platforms Equipped with Advanced APIs
The A2P SMS market report provides an in-depth analysis of the global A2P SMS market for the period 2014 – 2024, wherein 2015 is the base year and the years from 2016 to 2024 is the forecast period. Data for 2014 has been included as historical information. The report covers all the prevalent trends playing a major role in the growth of the A2P SMS market over the forecast period.